#07029: DMP1 as a drug target for bone diseases
………………………………………………………………………………………………………………
TECH FIELD(S)
Medical- Therapeutics
………………………………………………………………………………………………………………
FEATURES
We have discovered and validated dentin matrix protein-1 (DMP-1) as a target for bone formation. Either agonists or antagonists could be engineered based on this target or fragments of the target protein to treat disorders by regulating bone mineral density.
………………………………………………………………………………………………………………
BENEFITS
- Improves bone formation over control
………………………………………………………………………………………………………………
INVENTOR(S)
Dr. Kenneth White
………………………………………………………………………………………………………………
INTELLECTUAL PROPERTY STATUS
Patent Pending
………………………………………………………………………………………………………………
CONTACT INFORMATION
For additional information on this technology, please contact Kun Ma, Business Development Manager, IURTC:
Indiana University Research & Technology Corporation
351 West 10th Street
Indianapolis, IN 46202
Telephone: 317.278.1958
kunma@iu.edu
Still have a question? Ask here!


